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Abstract
Background:  Oncocytomas are benign tumors of the kidney that are usually diagnosed
postoperatively due to differential diagnostic problems from renal cell carcinoma. Although the
latter are neoplasms that have been associated with erythrocytosis in 3.5% of cases, there are no
reports in the literature about a similar occurrence in oncocytomas.
Case presentation: In this case report we present a unique case of a right lower pole
oncocytoma associated with erythrocytosis. Erythrocytosis subsided after partial nephrectomy.
Conclusion: Erythrocytosis can sometimes occur in association with renal oncocytomas.
Background
Under normal circumstances, erythropoietin is produced
in the kidney along with a variety of other substances like
renin and 1,25 dihydroxycholecalciferol. Paraneoplastic
syndromes such as hypertension, anemia, pyrexia and
hypercalcemia are described in up to 20% of patients with
renal cell carcinomas, and most of them subside after rad-
ical nephrectomy. Erythrocytosis occurs as a paraneoplas-
tic syndrome in 3.5% of patients with renal cell
carcinoma. Polycythemia is usually attributed to patho-
logic erythropoietin production by the tumor or by the
adjacent normal parenchyma in response to hypoxia
induced by tumor growth [1]. Although cases of concom-
itant polycythemia have been reported for a variety of uro-
logic tumors, there are no reports about a possible
association with renal oncocytomas. In this case report we
present a unique case of renal oncocytoma associated
with polycythemia.
Case presentation
A 41-year-old man presented in March 2005 to the
internist due to frequent headaches and plethoric face.
The CBC results showed a hematocrit of 65.1%. The
number of red cells was elevated: 7,32 × 106/mm3. The
mean corpuscular volume (MCV) was within normal lev-
els: 88,9 fl. Oxygen saturation was 99%. The patient was a
non-smoker. Hemoglobin was 21.7 g/dl, with all other
hematological, biochemical and urine examinations
being normal, apart from a small cholesterol (232 mg/dl)
and GPT (72 U/L) level elevation. The patient was taking
no medications and his medical and surgical history was
clear.
Findings of the abdominal ultrasound examination were
normal, apart from a solid mass on the lower pole of the
right kidney, measuring 8.1 × 6.1 cm, with calcifications.
The left kidney was normal. On subsequent CT and MRI
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examination this mass was enhancing. It measured 6 × 6
× 7 cm and the differential diagnosis included oncocy-
toma and renal cell carcinoma. There was evidence of a
tumor pseudocapsule with similar uptake to that of the
normal renal parenchyma and a central part showing
homogeneously diminished contrast uptake. No central
scar was detected. Furthermore, the mass appeared to dis-
tort the lower pole calyces of the right kidney. No renal
vein invasion or lymph node enlargement was noted.
Erythropoietin level was 17.4 mIU/ml (normal range: 9–
26 mIU/ml).
Subsequently, after phlebotomy (twice) to prevent peri-
operative thrombotic complications, the patient was sub-
jected to open partial nephrectomy via a flank approach.
This decision was based on the fact that the patient was
young and had a relatively higher probability to develop
chronic renal insufficiency had he been subjected to radi-
cal nephrectomy. Another reason was the favorable
peripheral location of the tumor and some recent evi-
dence that tumors>4 cm can be treated by partial nephrec-
tomy [2]. Macroscopically, the tumor demonstrated a
brownish color. It was solid, well circumscribed and
showed no areas of necrosis. A central scar was apparent
on macroscopic examination. Microscopically, the tumor
showed the morphological and immunohistochemical
characters of oncocytoma (vimentin (-), CK7 (-), CD10
(+)).
The hematocrit levels dropped to normal levels in the
perioperative period (probably due to phlebotomy and
blood loss during the operation). Because of the need to
closely follow his postoperative status, the patient was dis-
charged from the hospital on the 11th postoperative day
after an uneventful recovery period. On follow-up exami-
nation 1, 3 and 6 months later the hematocrit remained
normal (42 to 43%, hemoglobin 14–14.5 g/dl) and after
9 months the hematocrit was 42.5%. Follow-up MRI at 9
months was normal and erythropoietin levels dropped to
14.5 mIU/ml one year after the operation.
Conclusion
About 7% of surgically excised renal neoplasms are onco-
cytomas [3]. Most are asymptomatic at presentation and
are discovered incidentally during evaluation for nonuro-
logical problems, whereas hematuria and pain occur in a
minority of patients. Radiologically, a central scar is often
found on ultrasound and CT, however, this is considered
nonspecific and occurs in only 33% of oncocytomas [3].
Because of the lack of pathognomonic radiographic signs,
the diagnosis of oncocytoma is rarely made without oper-
ative exploration.
Paraneoplastic phenomena have not been reported for
renal oncocytomas. However, paraneoplastic manifesta-
tions are present in up to 20% of renal cell carcinomas,
sometimes being the first clinical presentation, and most
of them subside after surgical treatment of the tumor [4].
Erythropoietin has been immunolocalized to the cyto-
plasm of renal cell carcinoma cells in the majority of cases
with clinical erythrocytosis [5]. In a study of 165 renal cell
carcinomas by Ljungberg et al, 33% of renal cell carcino-
mas had elevated serum erythropoietin, however, no cor-
relation between erythrocytosis and elevated serum
erythropoietin was found [6]. From a clinical point this
probably means that erythropoietin is not the sole factor
responsible for erythrocytosis in those patients, as was the
case in this patient.
This is the first report of an oncocytoma with associated
erythrocytosis. In general, erythrocytosis can have various
causes like smoking, living in high altitude, sleep apnea,
chronic lung disease, hemoglobin mutations or renal dis-
ease, which were excluded during diagnostic workup. The
serum erythropoietin levels were within the normal range
in this case and dropped by 17% one year after the opera-
tion, in parallel with stabilisation of the hematocrit to
normal levels. The possibility that erythrocytosis was a
result of the response to tumor-induced hypoxia can not
be excluded. The contribution of erythropoietin to eryth-
rocytosis in this particular case is unclear, however, the
fact that the erythrocytosis was corrected after tumor
resection strongly suggests that this was a tumor-related
occurence.
Preoperative MRI Figure 1
Preoperative MRI. MRI showing a solid right lower pole 
mass, well circumscribed with inhomogeneous internal struc-
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Postoperative MRI Figure 2
Postoperative MRI. Follow-up MRI at 9 months postoper-
atively showing normal remaining kidney with scar formation.